| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 16.06. | Nurix Therapeutics, Inc.: Nurix Therapeutics Presents Positive Results from Ongoing Clinical Trial of NX-5948 in Patients with Relapsed Refractory Chronic Lymphocytic Leukemia (CLL) at the European Hematology Association Congress (EHA2024) | 177 | GlobeNewswire (Europe) | Objective response rate of 69.2% observed in heavily pretreated patient population including patients with BTK inhibitor resistance mutations Clinical responses in CLL patients were rapid and deepening... ► Artikel lesen | |
| 16.06. | Regeneron Pharmaceuticals, Inc.: Updated Linvoseltamab Data Showcase Continued Deepening of Responses in Patients with Heavily Pre-Treated Multiple Myeloma | 258 | GlobeNewswire (Europe) | At 14-months median follow-up in the pivotal trial, 50% of patients achieved a complete response or better and a 71% overall response rate, as presented in an EHA oral presentation and simultaneously... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| SUPER MICRO COMPUTER | 3.988 |
| EVOTEC | 3.183 |
| TUI | 2.809 |
| NVIDIA | 2.747 |
| BAYER | 2.663 |
| NEL | 2.473 |
| RENK GROUP | 1.789 |
| RHEINMETALL | 1.707 |
| TESLA | 1.307 |
| PALANTIR TECHNOLOGIES | 1.282 |
| VOLKSWAGEN | 1.268 |
| DEUTSCHE BANK | 1.151 |
| PLUG POWER | 1.071 |
| AMAZON | 1.045 |
| BYD | 1.044 |
| MICROSTRATEGY | 1.043 |
| PROSIEBENSAT.1 | 1.029 |
| BASF | 1.023 |
| COMMERZBANK | 1.019 |
| MERCEDES-BENZ | 948 |
| THYSSENKRUPP | 935 |
| ALLIANZ | 888 |
| JINKOSOLAR | 888 |
| AIXTRON SE | 881 |
| DEUTSCHE TELEKOM | 875 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
